TLSI
TLSI clinical trials: TriSalus Life Sciences, Inc.
Every trial on ClinicalTrials.gov where TriSalus Life Sciences, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 13
- Trials linked
- 3
- As lead sponsor
- 10
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
TLSI on the catalyst calendar · TLSI registry changes
- Primary completion Jul 31, 2024ActualPhase 1/Phase 2NCT05220722Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver TumorsTriSalus Life Sciences, Inc. · Hepatocellular CarcinomaTerminatedTLSILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 17, 2024ActualPhase 1NCT04935229Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic...TriSalus Life Sciences, Inc. · Metastatic Uveal Melanoma in the LiverTerminatedTLSILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2027Sponsor estimatePhase 1NCT05607953Pressure Enabled Intrapancreatic Delivery of SD-101 With Checkpoint Blockade for Locally Advanced Pancreatic AdenocarcinomaTriSalus Life Sciences, Inc. · Locally Advanced Pancreatic AdenocarcinomaActive, not recruitingTLSILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 1, 2027Sponsor estimateNo phase registeredNCT06868459Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter RegistrySarasota Memorial Health Care System · Hyperthyroidism; GoiterEnrolling by invitationTLSICollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2027Sponsor estimateNo phase registeredNCT05743842TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry...M.D. Anderson Cancer Center · Liver CancerActive, not recruitingTLSICollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 31, 2028Sponsor estimateNo phase registeredNCT07444645PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And...M.D. Anderson Cancer Center · TumorRecruitingTLSICollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2028Sponsor estimateNo phase registeredNCT07791446End Hole vs. Pressure-Modulated Delivery of Y-90 Resin Microspheres to Liver Metastases.Stanford University · Liver MetastasesNot yet recruitingTLSICollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2027Sponsor estimatePhase 1NCT06710223Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and TremelimumabUniversity of California, San Diego · Hepatocellular CarcinomaActive, not recruitingTLSICollaboratorBSXCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 16, 2026ActualNo phase registeredNCT05128032Pressure-enabled Delivery in Radioembolization (TriNav Study)Massachusetts General Hospital · Liver CancerCompletedTLSICollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 30, 2026Sponsor estimateNo phase registeredNCT06204159Lipiodol Deposition Using Endhole vs. Pressure-Modulated DeliveryAbramson Cancer Center at Penn Medicine · Hepatocellular CarcinomaActive, not recruitingTLSICollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 31, 2025ActualPhase 2NCT03007732Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADTDavid Oh · Prostatic NeoplasmsCompletedTLSICollaboratorMRKCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 15, 2025ActualNo phase registeredNCT06106633Pain Reduction and Ovarian Perfusion Following Uterine Fibroid EmbolizationMassachusetts General Hospital · Uterine BleedingTerminatedTLSICollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 4, 2021ActualPhase 1NCT04270929Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic CarcinomaRoger Williams Medical Center · Pancreatic AdenocarcinomaWithdrawnTLSICollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 13 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner